Roxithromycin Reduces the Degree of Bronchial Hyperresponsiveness in Children With Asthma
Toshio Shimizu(Kansai Medical University), Takayoshi Kuroume(Gunma University), Kenichi Tokuyama(Gunma University), Hiroyuki Mochizuki(Gunma University), Masahiko Katô(Gunma University), Akihiro Morikawa(Gunma University)
Cited by 69
Related Papers
E-CELL: software environment for whole-cell simulation.
|Bioinformatics|1999|765
Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody Cetuximab
|Science Translational Medicine|2011|670
The Clinical Effect of the Dual-Targeting Strategy Involving PI3K/AKT/mTOR and RAS/MEK/ERK Pathways in Patients with Advanced Cancer
|Clinical Cancer Research|2012|432